HARP logo

Harpoon Therapeutics, Inc. Common Stock

HARP

HARP: Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

more

Show HARP Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of HARP by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by HARP's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Single chain variable fragment cd3 binding proteins Apr. 11, 2023
  • Patent Title: Mesothelin binding proteins Mar. 21, 2023
  • Patent Title: Inducible monovalent antigen binding protein Dec. 27, 2022
  • Patent Title: Single domain serum albumin binding protein Sep. 27, 2022
  • Patent Title: Flt3 binding proteins and methods of use Nov. 23, 2021
  • Patent Title: Trispecific proteins and methods of use Oct. 05, 2021
  • Patent Title: Trispecific binding proteins and methods of use Mar. 23, 2021
  • Patent Title: B cell maturation antigen binding proteins Feb. 23, 2021
  • Patent Title: Prostate specific membrane antigen binding protein Dec. 01, 2020
  • Patent Title: Psma targeting trispecific proteins and methods of use Nov. 24, 2020
  • Patent Title: Dll3 binding proteins and methods of use Oct. 27, 2020
  • Patent Title: Msln targeting trispecific proteins and methods of use Aug. 04, 2020
  • Patent Title: Single chain variable fragment cd3 binding proteins Jan. 28, 2020
  • Patent Title: Mesothelin binding proteins Jan. 28, 2020
  • Patent Title: Single domain serum albumin binding protein Oct. 16, 2018
  • Patent Title: Single chain variable fragment cd3 binding proteins Sep. 04, 2018
  • Patent Title: Trispecific binding proteins and methods of use Jul. 18, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of HARP in WallStreetBets Daily Discussion

HARP News

Recent insights relating to HARP

CNBC Recommendations

Recent picks made for HARP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HARP

Corporate Flights

Flights by private jets registered to HARP